EGFR and neoplasm: Previously, miR-146a-5p had been classified as a tumor suppressor miR in non-small cell lung cancer25 by functionally inhibiting cell growth and migration, but our data shows that it may also contribute to TKI resistance by reducing EGFR availability and increasing reliance on bypass pathways.